Zilretta is an extended-release corticosteroid treatment approved for managing knee pain caused by osteoarthritis. With just one injection, Zilretta provides significant relief for up to three months, offering a convenient and effective solution for individuals suffering from knee pain. It is a registered trademark of Pacira Therapeutics, Inc., a subsidiary of Pacira BioSciences, Inc.
The American Academy of Orthopaedic Surgeons (AAOS) regularly updates its treatment guidelines for osteoarthritis of the knee, providing healthcare professionals with the latest information on effective treatments. Zilretta is recommended by AAOS as a safe and reliable option for managing knee pain, and it has been proven to reduce pain and improve the quality of life for many individuals, including NFL Hall of Famer Rod Woodson. Zilretta is administered through a single injection and is designed to provide long-lasting relief, making it a convenient and beneficial treatment option for those suffering from knee osteoarthritis.
Generated from the website